Zobrazeno 1 - 10
of 1 762
pro vyhledávání: '"James, Pike"'
Autor:
STORM, LANCE1
Publikováno v:
Australian Journal of Parapsychology. Jun2023, Vol. 23 Issue 1, p35-57. 23p.
Autor:
Chenhan Sun, Yusheng Jia, Hainan Li, Xuanqi Qiao, Mi Tang, Meiyan Geng, Eddie Jones, James Pike, Mia Unsworth, Min Hu
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Multiple sclerosis (MS) is uncommon in China and the standard of care is underdeveloped, with limited utilization of disease-modifying treatment (DMT). An understanding of real-world disease burden (including direct medical, non-medical, and
Externí odkaz:
https://doaj.org/article/da884d83338a44c0b4a1213fe516e077
Autor:
Zahi Touma, Karen H. Costenbader, Ben Hoskin, Christian Atkinson, David Bell, James Pike, Pamela Berry, Chetan S. Karyekar
Publikováno v:
BMC Rheumatology, Vol 8, Iss 1, Pp 1-12 (2024)
Abstract Background Limited real-world data exists on clinical outcomes in systemic lupus erythematosus (SLE) patients by SLE Disease Activity Index 2000 (SLEDAI-2 K), hereafter, SLEDAI. We aimed to examine the association between SLEDAI score and cl
Externí odkaz:
https://doaj.org/article/18017c5d94cb44c78d40d02f43e745f3
Publikováno v:
Health and Quality of Life Outcomes, Vol 21, Iss 1, Pp 1-13 (2023)
Abstract Background Nonalcoholic steatohepatitis (NASH) is a chronic progression of nonalcoholic fatty liver disease, which can negatively impact the health-related quality of life (HRQoL) of affected individuals. HRQoL in NASH has been assessed usin
Externí odkaz:
https://doaj.org/article/b0898d69db884428933ac134b9af275b
Publikováno v:
BMC Neurology, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Many patients with Parkinson’s disease (PD) who receive carbidopa/levodopa experience symptom reemergence or worsening, or “OFF” episodes. This study assessed the association of “OFF” episodes with health-related quality
Externí odkaz:
https://doaj.org/article/990794baf49e4ee3b89788958fb9353e
Autor:
Alison Davie, Gebra Cuyun Carter, Alex Rider, James Pike, Katie Lewis, Abigail Bailey, Gregory L. Price, Francois Ringeisen, Xavier Pivot
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-15 (2020)
Abstract Background Endocrine therapy (ET)-based regimens are the mainstay of treatment for patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2−) advanced breast cancer. With the introduction of new t
Externí odkaz:
https://doaj.org/article/7fe4847e3d934667a90f1ffc58d8e438
Autor:
Xin Hui S Chan, Ilsa L Haeusler, Yan Naung Win, James Pike, Borimas Hanboonkunupakarn, Maryam Hanafiah, Sue J Lee, Abdoulaye Djimdé, Caterina I Fanello, Jean-René Kiechel, Marcus Vg Lacerda, Bernhards Ogutu, Marie A Onyamboko, André M Siqueira, Elizabeth A Ashley, Walter Rj Taylor, Nicholas J White
Publikováno v:
PLoS Medicine, Vol 18, Iss 9, p e1003766 (2021)
BackgroundAmodiaquine is a 4-aminoquinoline antimalarial similar to chloroquine that is used extensively for the treatment and prevention of malaria. Data on the cardiovascular effects of amodiaquine are scarce, although transient effects on cardiac
Externí odkaz:
https://doaj.org/article/9f5554785c2245449964647e4dd37413
Autor:
L. Elise Horvath Walsh, Alex Rider, James Piercy, James Pike, Samuel Wilson, Bhavik J. Pandya, Bruno C. Medeiros
Publikováno v:
Oncology and Therapy, Vol 7, Iss 1, Pp 67-81 (2019)
Abstract Introduction There is limited understanding concerning the health-related quality of life (HRQoL) in acute myeloid leukemia (AML) patients. Due to an overlap of symptoms, it can be difficult to separate disease versus treatment-related effec
Externí odkaz:
https://doaj.org/article/21006648048c4562843b2441416832e6
Autor:
Kincaid, Gerald L.
Publikováno v:
The English Journal, 1973 May 01. 62(5), 838-839.
Externí odkaz:
https://www.jstor.org/stable/814322
Publikováno v:
Journal of Allergy and Clinical Immunology: Global. 2:51-60